✦ LIBER ✦

Comparison of standard-dose and low-dose gemcitabine regimens in pancreatic adenocarcinoma patients: a prospective randomized trial

✍ Scribed by Hiroki Sakamoto; Masayuki Kitano; Yoichirou Suetomi; Yoshifumi Takeyama; Harumasa Ohyanagi; Takuya Nakai; Chikao Yasuda; Masatoshi Kudo

Publisher: Springer Japan
Year: 2006
Tongue: English
Weight: 389 KB
Volume: 41
Category: Article
ISSN: 0944-1174
DOI: 10.1007/s00535-005-1724-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of biweekly high dose g

A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinoma

✍ Herbert Ulrich-Pur; Gabriela V. Kornek; Markus Raderer; Karin Haider; Werner Kwa 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 2 views

Metabolic inefficacy of a short-term low

Metabolic inefficacy of a short-term low-dose insulin regimen in critically ill patients: a randomized, placebo-controlled trial

✍ Ulrike Holzinger; Alexandra Zauner; Petra Nimmerrichter; Mark Schiefermeier; Kla 📂 Article 📅 2004 🏛 Springer Vienna 🌐 English ⚖ 72 KB

Evaluation of renal function in liver tr

Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: A multicenter randomized clinical trial

✍ Eric M. Yoshida; Paul J. Marotta; Paul D. Greig; Norman M. Kneteman; Denis Marle 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Posttransplant chronic renal failure, secondary to calcineurin inhibitor agents, is emerging as a major problem in liver transplantation. We report a randomized clinical trial comparing daclizumab, delayed low-dose tacrolimus (target trough level 4-8 ng/mL, starting day 4-6), Investigational Arm (n

A randomized phase II trial of personali

A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancer

✍ Masanori Noguchi; Tatsuyuki Kakuma; Hirotsugu Uemura; Yasutomo Nasu; Hiromi Kumo 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 422 KB

The cognitive sequelae of standard-dose

The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma : Results of a prospective, randomized, longitudinal trial

✍ Paul Maruff; Marina G. Falleti; Alexander Collie 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

The cognitive sequelae of standard-dose

The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma : Results of a prospective, randomized, longitudinal trial

✍ Jeffrey S. Wefel; Renato Lenzi; Richard L. Theriault; Robert N. Davis; Christina 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

## Abstract ## BACKGROUND Retrospective trials have reported that chemotherapy‐induced cognitive dysfunction was experienced by a subset of patients with breast carcinoma. However, recent evidence indicated that a subset also exhibited impaired cognitive function at baseline, before the start of c